SHAKERIA BROWN: Open Payments
NPI 1043818966 · NAUGATUCK, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 4 payments from 3 companies in 2025. Trend: 2023 $129 · 2024 $421 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, INGREZZA, REXULTI.
Industry payments across CT — which companies pay providers there.
